Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.44
+0.20 (0.68%)
At close: Feb 27, 2026, 4:00 PM EST
29.51
+0.07 (0.24%)
After-hours: Feb 27, 2026, 6:40 PM EST
Genmab Revenue
In the year 2025, Genmab had annual revenue of $3.72B with 19.19% growth. Genmab had revenue of $1.06B in the quarter ending December 31, 2025, with 3.03% growth.
Revenue (ttm)
$3.72B
Revenue Growth
+19.19%
P/S Ratio
4.84
Revenue / Employee
$1,251,261
Employees
2,973
Market Cap
18.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.72B | 599.00M | 19.19% |
| Dec 31, 2024 | 3.12B | 731.00M | 30.59% |
| Jan 1, 2024 | 2.39B | 305.95M | 14.68% |
| Dec 31, 2022 | 2.08B | 796.62M | 61.88% |
| Dec 31, 2021 | 1.29B | -374.23M | -22.52% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Incyte | 5.14B |
| BioNTech SE | 3.70B |
| BioMarin Pharmaceutical | 3.22B |
| Royalty Pharma | 2.38B |
| Moderna | 1.94B |
| Ionis Pharmaceuticals | 944.00M |
| Ascendis Pharma | 845.52M |
| BridgeBio Pharma | 502.08M |
GMAB News
- 1 day ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire
- 1 day ago - Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab - GlobeNewsWire
- 3 days ago - Genmab to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 days ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 5 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 8 days ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire
- 8 days ago - Novo Nordisk nominates three new board directors, two with pharma experience - Seeking Alpha
- 9 days ago - Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Benzinga